Home The Active Ingredient Matrix Gymnema sylvestre (Gymnemic Acid)

Formulation Intelligence

Gymnema sylvestre (Gymnemic Acid)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Gymnema sylvestre (Gymnemic Acid).

Gymnema sylvestre acts as a potent hypoglycemic agent by competitively inhibiting glucose absorption in the small intestine and stimulating insulin secretion through the regeneration of pancreatic beta-cells.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

11953901

Molecular Weight

550.5 g/mol

XLogP3 (Lipophilicity)

-0.9

IUPAC Name

(2S)-1-[(2E)-2-[(2S)-2,6-dicarboxy-2,3-dihydro-1H-pyridin-4-ylidene]ethylidene]-6-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydroindol-1-ium-2-carboxylate

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Chromium Picolinate for enhanced insulin receptor sensitivity and glucose disposal
  • Berberine HCl for synergistic AMPK activation and improved glycemic control

Biological Formulation Enhancers

  • Piperine for increased intestinal permeability of triterpene saponins
  • Hydroxypropyl-beta-cyclodextrin for improved aqueous solubility and dissolution rates of gymnemic acids

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Gymnema sylvestre (Gymnemic Acid) across standard consumer modalities.

💊 Standard Capsules

The highly hygroscopic nature of concentrated gymnemic acid extracts necessitates the use of moisture-resistant excipients and specialized desiccant packaging to prevent powder agglomeration.

🍬 Gummy & Pectin Formats

The intense, lingering bitterness of gymnemic acids requires complex organoleptic masking agents and can potentially disrupt the cross-linking stability of pectin-based matrices.

🔬 Thin-Film Oral Strips

The high therapeutic dosage required for effective glucose modulation typically exceeds the limited active ingredient payload capacity of standard thin-film polymer matrices.

For Brand Founders

Formulate with Gymnema sylvestre (Gymnemic Acid)

Ready to launch a product featuring Gymnema sylvestre (Gymnemic Acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Gymnema sylvestre (Gymnemic Acid) Bioavailability

Need absolute proof that your Gymnema sylvestre (Gymnemic Acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Gymnema sylvestre (Gymnemic Acid) Degradation Testing

Is your Gymnema sylvestre (Gymnemic Acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation